vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and CPS TECHNOLOGIES CORP (CPSH). Click either name above to swap in a different company.

CPS TECHNOLOGIES CORP is the larger business by last-quarter revenue ($8.2M vs $6.2M, roughly 1.3× Alector, Inc.). On growth, CPS TECHNOLOGIES CORP posted the faster year-over-year revenue change (38.3% vs -88.5%). CPS TECHNOLOGIES CORP produced more free cash flow last quarter ($-487.0K vs $-184.1M). Over the past eight quarters, CPS TECHNOLOGIES CORP's revenue compounded faster (17.8% CAGR vs -37.4%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

ALEC vs CPSH — Head-to-Head

Bigger by revenue
CPSH
CPSH
1.3× larger
CPSH
$8.2M
$6.2M
ALEC
Growing faster (revenue YoY)
CPSH
CPSH
+126.8% gap
CPSH
38.3%
-88.5%
ALEC
More free cash flow
CPSH
CPSH
$183.6M more FCF
CPSH
$-487.0K
$-184.1M
ALEC
Faster 2-yr revenue CAGR
CPSH
CPSH
Annualised
CPSH
17.8%
-37.4%
ALEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALEC
ALEC
CPSH
CPSH
Revenue
$6.2M
$8.2M
Net Profit
$12.6K
Gross Margin
14.9%
Operating Margin
-1.2%
Net Margin
0.2%
Revenue YoY
-88.5%
38.3%
Net Profit YoY
-1696.9%
101.3%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
CPSH
CPSH
Q4 25
$6.2M
$8.2M
Q3 25
$3.3M
$8.8M
Q2 25
$7.9M
$8.1M
Q1 25
$3.7M
$7.5M
Q4 24
$54.2M
$5.9M
Q3 24
$15.3M
$4.2M
Q2 24
$15.1M
$5.0M
Q1 24
$15.9M
$5.9M
Net Profit
ALEC
ALEC
CPSH
CPSH
Q4 25
$12.6K
Q3 25
$-34.7M
$208.0K
Q2 25
$-30.5M
$103.8K
Q1 25
$-40.5M
$96.0K
Q4 24
$-2.1M
$-995.2K
Q3 24
$-42.2M
$-1.0M
Q2 24
$-38.7M
$-954.3K
Q1 24
$-36.1M
$-143.2K
Gross Margin
ALEC
ALEC
CPSH
CPSH
Q4 25
14.9%
Q3 25
17.1%
Q2 25
16.5%
Q1 25
16.4%
Q4 24
-4.6%
Q3 24
-12.3%
Q2 24
-4.6%
Q1 24
15.3%
Operating Margin
ALEC
ALEC
CPSH
CPSH
Q4 25
-1.2%
Q3 25
-1153.6%
3.1%
Q2 25
-433.6%
1.7%
Q1 25
-1216.5%
1.7%
Q4 24
-13.4%
-22.2%
Q3 24
-315.7%
-35.0%
Q2 24
-302.4%
-26.1%
Q1 24
-275.0%
-4.4%
Net Margin
ALEC
ALEC
CPSH
CPSH
Q4 25
0.2%
Q3 25
-1063.4%
2.4%
Q2 25
-387.7%
1.3%
Q1 25
-1101.6%
1.3%
Q4 24
-3.8%
-16.8%
Q3 24
-275.2%
-24.6%
Q2 24
-256.4%
-19.0%
Q1 24
-227.0%
-2.4%
EPS (diluted)
ALEC
ALEC
CPSH
CPSH
Q4 25
$0.00
Q3 25
$-0.34
$0.01
Q2 25
$-0.30
$0.01
Q1 25
$-0.41
$0.01
Q4 24
$-0.02
$-0.07
Q3 24
$-0.43
$-0.07
Q2 24
$-0.40
$-0.07
Q1 24
$-0.38
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
CPSH
CPSH
Cash + ST InvestmentsLiquidity on hand
$256.0M
$13.2M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$24.6M
Total Assets
$293.2M
$29.5M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
CPSH
CPSH
Q4 25
$256.0M
$13.2M
Q3 25
$291.1M
$4.3M
Q2 25
$307.3M
$3.4M
Q1 25
$354.6M
$3.0M
Q4 24
$413.4M
$4.3M
Q3 24
$457.2M
$5.7M
Q2 24
$503.3M
$7.1M
Q1 24
$562.1M
$8.7M
Total Debt
ALEC
ALEC
CPSH
CPSH
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
$8.1K
Q3 24
$20.1K
Q2 24
$31.9K
Q1 24
$43.5K
Stockholders' Equity
ALEC
ALEC
CPSH
CPSH
Q4 25
$30.6M
$24.6M
Q3 25
$57.7M
$15.1M
Q2 25
$71.2M
$14.9M
Q1 25
$94.6M
$14.7M
Q4 24
$126.8M
$14.5M
Q3 24
$118.9M
$15.4M
Q2 24
$150.6M
$16.4M
Q1 24
$178.9M
$17.3M
Total Assets
ALEC
ALEC
CPSH
CPSH
Q4 25
$293.2M
$29.5M
Q3 25
$335.3M
$20.4M
Q2 25
$356.4M
$19.4M
Q1 25
$408.3M
$19.2M
Q4 24
$468.3M
$18.9M
Q3 24
$516.0M
$19.2M
Q2 24
$570.7M
$20.1M
Q1 24
$635.5M
$21.2M
Debt / Equity
ALEC
ALEC
CPSH
CPSH
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
CPSH
CPSH
Operating Cash FlowLast quarter
$-184.0M
$243.6K
Free Cash FlowOCF − Capex
$-184.1M
$-487.0K
FCF MarginFCF / Revenue
-2951.3%
-5.9%
Capex IntensityCapex / Revenue
0.7%
8.9%
Cash ConversionOCF / Net Profit
19.34×
TTM Free Cash FlowTrailing 4 quarters
$-326.5M
$-479.6K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
CPSH
CPSH
Q4 25
$-184.0M
$243.6K
Q3 25
$-32.5M
$1.1M
Q2 25
$-49.0M
$649.3K
Q1 25
$-60.8M
$-1.3M
Q4 24
$-55.0M
$-3.5M
Q3 24
$-50.7M
$-1.2M
Q2 24
$-62.8M
$-1.0M
Q1 24
$-61.3M
$128.9K
Free Cash Flow
ALEC
ALEC
CPSH
CPSH
Q4 25
$-184.1M
$-487.0K
Q3 25
$-32.5M
$876.8K
Q2 25
$-49.1M
$476.4K
Q1 25
$-60.8M
$-1.3M
Q4 24
$-55.2M
$-4.5M
Q3 24
$-50.9M
$-1.3M
Q2 24
$-63.1M
$-1.6M
Q1 24
$-61.9M
$-134.5K
FCF Margin
ALEC
ALEC
CPSH
CPSH
Q4 25
-2951.3%
-5.9%
Q3 25
-997.6%
10.0%
Q2 25
-623.0%
5.9%
Q1 25
-1655.0%
-17.9%
Q4 24
-101.8%
-75.3%
Q3 24
-332.1%
-29.8%
Q2 24
-418.6%
-31.8%
Q1 24
-389.3%
-2.3%
Capex Intensity
ALEC
ALEC
CPSH
CPSH
Q4 25
0.7%
8.9%
Q3 25
0.3%
2.0%
Q2 25
0.1%
2.1%
Q1 25
0.5%
1.2%
Q4 24
0.3%
16.8%
Q3 24
1.4%
1.9%
Q2 24
2.2%
11.0%
Q1 24
3.4%
4.5%
Cash Conversion
ALEC
ALEC
CPSH
CPSH
Q4 25
19.34×
Q3 25
5.05×
Q2 25
6.25×
Q1 25
-13.05×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons